Aberrant expression of TRAIL in B chroni
β
Paola Secchiero; Mario Tiribelli; Elisa Barbarotto; Claudio Celeghini; Angela Mi
π
Article
π
2005
π
John Wiley and Sons
π
English
β 252 KB
π 2 views
Analysis of peripheral blood (>85% CD19+/CD5+ B) lymphocytes, obtained from 44 patients affected by B chronic lymphoid leukemia (B-CLL), showed that surface TNF-related apoptosis inducing ligand (TRAIL) was expressed in all samples and at higher levels with respect to unfractionated lymphocytes and